Advances in the knowledge of breast cancer stem cells. A review

被引：12

作者：

Schwarz-Cruz y Celis, Angela ^{[1
,2
]}

Espinosa, Magali ^{[1
]}

Maldonado, Vilma ^{[1
]}

Melendez-Zajgla, Jorge ^{[1
]}

机构：

[1] Natl Inst Genom Med, Funct Genom Lab, Perifer Sur 4809 Col Arenal Tepepan, Mexico City, DF, Mexico

[2] Univ Nacl Autonoma Mexico, Mexico City 04510, DF, Mexico

来源：

HISTOLOGY AND HISTOPATHOLOGY | 2016年 / 31卷 / 06期

关键词：

Breast cancer; Cancer stem cells; Breast cancer stem cells; Markers; Therapeutic resistance; EPITHELIAL-MESENCHYMAL TRANSITION; ACUTE MYELOID-LEUKEMIA; SIDE POPULATION CELLS; ALDEHYDE DEHYDROGENASE; INITIATING CELLS; DIFFERENTIAL EXPRESSION; COLORECTAL-CANCER; CD133(+) CELLS; MARKERS CD44; CLAUDIN-LOW;

D O I：

10.14670/HH-11-718

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Much effort has been made by researchers to elucidate the complex biology of breast cancer stem cells (BCSCs), a small subset of breast tumor cells that display stem cell properties, drive tumor initiation, and growth. In recent years, it has been suggested that BCSCs could be responsible for the process of metastasis and the development of drug resistance. These findings make the need to find the distinguishing blend of markers that can recognize only BCSCs of the utmost importance in order to be able to design new targeted therapies. This review will summarize BCSCs' main features as well as the cell surface markers that are currently used to identify them.

引用

页码：601 / 612

页数：12

共 50 条

[21] Telomerase: a promising marker of biological immortality of germ, stem, and cancer cells. A review
Meeker, AK
Coffey, DS
BIOCHEMISTRY-MOSCOW, 1997, 62 (11) : 1323 - 1331
[22] Effect of therapeutic targeting of EMP2 on breast and endometrial cancer stem cells.
Wadehra, Madhuri
Kiyohara, Meagan
Ashki, Negin
Chan, Ann
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[23] Role of S100A10 in the metastatic colonization of breast cancer stem cells.
Shimono, Yohei
Yanagi, Hisano
Watanabe, Takashi
Nishimura, Tatsunori
Hayashi, Takanori
Okada, Seiji
Suzuki, Motoshi
Kawada, Kenji
Minami, Hironobu
Gotoh, Noriko
CANCER RESEARCH, 2021, 81 (13)
[24] The role of HSF1 in maintenance of β-catenin stability in breast cancer stem cells.
Chou, Shiuh-Dih
Calderwood, Stuart
FASEB JOURNAL, 2013, 27
[25] Connective tissue growth factor (CTGF) mediates metastases of breast cancer stem cells.
Zhong, Jing
Zhu, Xiaoping
Zhao, Hong
Wong, Stephen Tc
Wong, Stephen Tc
CANCER RESEARCH, 2013, 73 (08)
[26] Recent advances in cancer stem cells
Cho, Robert W.
Clarke, Michael F.
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2008, 18 (01) : 48 - 53
[27] Mesenchymal stem cells more effective than endothelial precursor cells in promoting malignancy of breast cancer cells.
Bagley, RG
Dash, AB
Weber, W
Sullivan, A
Yu, QD
Tubo, R
Teicher, BA
CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9002S - 9003S
[28] Cancer stem cells in breast cancer
Dittmer, Juergen
Rody, Achim
HISTOLOGY AND HISTOPATHOLOGY, 2013, 28 (07) : 827 - 838
[29] Breast stem cells and cancer
Farnie, G.
Clarke, R. B.
CANCER STEM CELLS: NOVEL CONCEPTS AND PROSPECTS FOR TUMOR THERAPY, 2007, 5 : 141 - 154
[30] Breast cancer stem cells
Polyak, K.
Shipitsin, M.
Campbell, L.
Yao, J.
EJC SUPPLEMENTS, 2008, 6 (09): : 3 - 3

← 1 2 3 4 5 →